FOR AUTHORS
Search
Search Results
##search.searchResults.foundPlural##
-
The impact of tocilizumab on hepatic enzyme levels in rheumatoid arthritis patients: a narrative review
1506PDF: 376SUPPLEMENTARY MATERIAL: 136HTML: 52 -
New antibiotic development: barriers and opportunities
3622PDF: 2026HTML: 2057 -
Insulin therapy in the hospital setting: a time for a change?
2977PDF: 1324HTML: 2195 -
-
Use of ursodeoxycholic acid in patients with hypertransaminasemia
1749PDF: 1240HTML: 1368 -
Antibiotic stewardship programs and the internist's role
2012PDF: 1156HTML: 661 -
The clinical impact of hypoglycemia in hospitalized patients
2445PDF: 1139HTML: 1004 -
The pharmacological deprescription in elderly patients
1523PDF: 488HTML: 37 -
-
Assessing the effect of implementing a central line care bundle on central line-associated bloodstream infections in a tertiary hospital in Saudi Arabia
3494PDF: 1087SUPPLEMENTARY MATERIAL: 359HTML: 524 -
-
CO04 | Safety Briefing in the critical area: the experience of the Urgency Medicine of ASL Biella P. Ariatta, I. Corniati, V. Bissacca, D.S. Di Massimo, F. Bertoncini | ASL Biella, Italy
245 -
-
Short versus long course antibiotic therapy for acute pyelonephritis in adults: a systematic review and meta-analysis
3997PDF: 1529Appendix: 642HTML: 1090 -
P41 | Efficacy and safety of Roxadustat in patients with anemia of dialysis-dependent chronic kidney disease with or without inflammation: pooled analysis of four phase 3 studies G. Choukroun1, A. Harkavyi2, V. Santos3, A. Jiletcovici3, L. Del Vecchio4 | 1CHU Amiens Picardie and Jules Verne University, Amiens, France, 2Astellas Pharma Europe, Addlestone, UK, 3Astellas Pharma, Inc., Northbrook, USA, 4Sant’Anna Hospital, ASST Lariana, Como, Italy
485 -
Stroke prevention in atrial fibrillation: findings from Tuscan FADOI Stroke Registry
1849PDF: 1413Appendix: 642HTML: 635 -
P42 | Efficacy and safety of roxadustat in patients with non-dialysis-dependent chronic kidney disease with or without inflammation: pooled analysis of four phase 3 studies G. Choukroun1, A. Harkavyi2, V. Santos3, A. Jiletcovici3, L. Del Vecchio4 | 1CHU Amiens Picardie and Jules Verne University, Amiens, France, 2Astellas Pharma Europe, Addlestone, UK, 3Astellas Pharma, Inc., Northbrook, USA, 4Sant’Anna Hospital, Como, Italy
195 -
Sodium-glucose cotransporter 2 inhibition in patients with liver cirrhosis and diabetes: a possible role in ascites control?
2334PDF: 748SUPPLEMENTARY MATERIAL: 358HTML: 112 -
P28 | Glecaprevir/pibrentasvir in HCV+ Lucanian patients N. Buccianti1, G. Zaccardo2, M. Pace2, N. Mecca2, C. Vita2, D. Ferrante2, F. Coviello2 | 1UOC Medicina Interna, Azienda Ospedaliera San Carlo, Potenza, 2UOC Medicina Interna, Azienda Ospedaliera San Carlo, Potenza, Italy
176 -
-
-
P65 | The Internist and Chronic Intestinal Diseases D. Ferrante1, G. Zaccardo2, N. Buccianti2, N. Mecca2, M. Pace2, V. Caterina2, F. Coviello2 | 1UOC Medicina Interna, Azienda Ospedaliera San Carlo, Potenza, 2UOC Medicina Interna, Potenza, Italy
224 -
The erectile dysfunction as a cardiovascular risk factor
1773PDF: 1073HTML: 1581 -
The doctor and the patient: doing too much or too little
1239PDF: 953HTML: 265
